(AROW) Arrow Financial - Ratings and Ratios
Deposits, Loans, Retirement, Insurance, Advisory
AROW EPS (Earnings per Share)
AROW Revenue
Description: AROW Arrow Financial October 24, 2025
Arrow Financial Corporation (NASDAQ:AROW) is a New York-based bank holding company that offers a full suite of commercial and consumer banking services across the United States. Its deposit franchise includes demand deposits, interest-bearing checking, savings, and various time-deposit products. On the lending side, Arrow originates commercial loans (term loans, lines of credit, and CRE financing), consumer installment loans, auto loans, and residential mortgage products such as home-equity loans and HELOCs. The firm also provides wealth-management services-including retirement planning, trust and estate administration-along with insurance brokerage and investment advisory capabilities, and it owns a real-estate investment trust.
Key operating metrics (Q2 2024) show a net interest margin of roughly 3.1%, a loan-to-deposit ratio of 78%, and a return on equity of 9.2%, all modestly above the regional-bank median. Loan growth has accelerated to 5.4% year-over-year, driven largely by commercial real-estate and consumer credit expansion, while credit quality remains stable with a non-performing loan ratio of 0.9%.
Given the sensitivity of regional banks to Federal Reserve rate policy and commercial-real-estate cycles, monitoring Arrow’s exposure to those sectors is essential; a deeper dive on ValueRay can help you quantify how these macro drivers may affect the stock’s upside potential.
AROW Stock Overview
| Market Cap in USD | 458m | 
| Sub-Industry | Regional Banks | 
| IPO / Inception | 1984-09-07 | 
AROW Stock Ratings
| Growth Rating | -6.33% | 
| Fundamental | 64.7% | 
| Dividend Rating | 57.4% | 
| Return 12m vs S&P 500 | -12.9% | 
| Analyst Rating | 3.0 of 5 | 
AROW Dividends
| Dividend Yield 12m | 2.88% | 
| Yield on Cost 5y | 3.72% | 
| Annual Growth 5y | 4.02% | 
| Payout Consistency | 93.5% | 
| Payout Ratio | 48.3% | 
AROW Growth Ratios
| Growth Correlation 3m | -42.2% | 
| Growth Correlation 12m | -1.5% | 
| Growth Correlation 5y | -34.9% | 
| CAGR 5y | -0.81% | 
| CAGR/Max DD 3y (Calmar Ratio) | -0.02 | 
| CAGR/Mean DD 3y (Pain Ratio) | -0.04 | 
| Sharpe Ratio 12m | -0.96 | 
| Alpha | -12.14 | 
| Beta | 0.776 | 
| Volatility | 30.97% | 
| Current Volume | 74.1k | 
| Average Volume 20d | 30.8k | 
| Stop Loss | 28.5 (-3.4%) | 
| Signal | 1.08 | 
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (34.4m TTM) > 0 and > 6% of Revenue (6% = 13.6m TTM) | 
| FCFTA 0.01 (>2.0%) and ΔFCFTA -0.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) | 
| NWC/Revenue -1673 % (prev -1393 %; Δ -280.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) | 
| CFO/TA 0.01 (>3.0%) and CFO 35.4m > Net Income 34.4m (YES >=105%, WARN >=100%) | 
| Net Debt (-45.9m) to EBITDA (31.8m) ratio: -1.44 <= 3.0 (WARN <= 3.5) | 
| Current Ratio 0.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) | 
| Outstanding Shares last Quarter (16.4m) change vs 12m ago -2.01% (target <= -2.0% for YES) | 
| Gross Margin 70.05% (prev 61.95%; Δ 8.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) | 
| Asset Turnover 5.03% (prev 4.98%; Δ 0.04pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) | 
| Interest Coverage Ratio 0.35 (EBITDA TTM 31.8m / Interest Expense TTM 78.7m) >= 6 (WARN >= 3) | 
Altman Z'' -5.27
| (A) -0.82 = (Total Current Assets 45.9m - Total Current Liabilities 3.83b) / Total Assets 4.59b | 
| (B) 0.02 = Retained Earnings (Balance) 93.0m / Total Assets 4.59b | 
| (C) 0.01 = EBIT TTM 27.2m / Avg Total Assets 4.50b | 
| (D) 0.03 = Book Value of Equity 106.5m / Total Liabilities 4.17b | 
| Total Rating: -5.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) | 
ValueRay F-Score (Strict, 0-100) 64.69
| 1. Piotroski 5.0pt = 0.0 | 
| 2. FCF Yield 6.55% = 3.28 | 
| 3. FCF Margin 12.93% = 3.23 | 
| 4. Debt/Equity 0.08 = 2.50 | 
| 5. Debt/Ebitda -1.44 = 2.50 | 
| 6. ROIC - WACC (= -3.40)% = -4.26 | 
| 7. RoE 8.44% = 0.70 | 
| 8. Rev. Trend 81.07% = 6.08 | 
| 9. EPS Trend 13.18% = 0.66 | 
What is the price of AROW shares?
Over the past week, the price has changed by +8.70%, over one month by +6.85%, over three months by +12.17% and over the past year by +5.76%.
Is Arrow Financial a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AROW is around 27.24 USD . This means that AROW is currently overvalued and has a potential downside of -7.63%.
Is AROW a buy, sell or hold?
- Strong Buy: 0
 - Buy: 0
 - Hold: 2
 - Sell: 0
 - Strong Sell: 0
 
What are the forecasts/targets for the AROW price?
| Issuer | Target | Up/Down from current | 
|---|---|---|
| Wallstreet Target Price | 33.5 | 13.6% | 
| Analysts Target Price | 33.5 | 13.6% | 
| ValueRay Target Price | 30.3 | 2.7% | 
AROW Fundamental Data Overview November 02, 2025
P/E Trailing = 15.2404
P/S = 3.1226
P/B = 1.1087
P/EG = 2.41
Beta = 0.776
Revenue TTM = 226.1m USD
EBIT TTM = 27.2m USD
EBITDA TTM = 31.8m USD
Long Term Debt = 28.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 33.6m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -45.9m USD (from netDebt column, last quarter)
Enterprise Value = 446.1m USD (458.4m + Debt 33.6m - CCE 45.9m)
Interest Coverage Ratio = 0.35 (Ebit TTM 27.2m / Interest Expense TTM 78.7m)
FCF Yield = 6.55% (FCF TTM 29.2m / Enterprise Value 446.1m)
FCF Margin = 12.93% (FCF TTM 29.2m / Revenue TTM 226.1m)
Net Margin = 15.22% (Net Income TTM 34.4m / Revenue TTM 226.1m)
Gross Margin = 70.05% ((Revenue TTM 226.1m - Cost of Revenue TTM 67.7m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 66.82%)
Tobins Q-Ratio = 0.10 (Enterprise Value 446.1m / Total Assets 4.59b)
Interest Expense / Debt = 57.93% (Interest Expense 19.5m / Debt 33.6m)
Taxrate = 22.74% (3.77m / 16.6m)
NOPAT = 21.1m (EBIT 27.2m * (1 - 22.74%))
Current Ratio = 0.01 (Total Current Assets 45.9m / Total Current Liabilities 3.83b)
Debt / Equity = 0.08 (Debt 33.6m / totalStockholderEquity, last quarter 417.7m)
Debt / EBITDA = -1.44 (Net Debt -45.9m / EBITDA 31.8m)
Debt / FCF = -1.57 (Net Debt -45.9m / FCF TTM 29.2m)
Total Stockholder Equity = 407.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.75% (Net Income 34.4m / Total Assets 4.59b)
RoE = 8.44% (Net Income TTM 34.4m / Total Stockholder Equity 407.9m)
RoCE = 6.24% (EBIT 27.2m / Capital Employed (Equity 407.9m + L.T.Debt 28.6m))
RoIC = 4.86% (NOPAT 21.1m / Invested Capital 433.2m)
WACC = 8.26% (E(458.4m)/V(492.1m) * Re(8.87%) + (debt cost/tax rate unavailable))
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.77%
[DCF Debug] Terminal Value 71.38% ; FCFE base≈29.8m ; Y1≈24.0m ; Y5≈16.5m
Fair Price DCF = 16.15 (DCF Value 265.4m / Shares Outstanding 16.4m; 5y FCF grow -23.34% → 3.0% )
EPS Correlation: 13.18 | EPS CAGR: 3.85% | SUE: 1.13 | # QB: 2
Revenue Correlation: 81.07 | Revenue CAGR: 13.60% | SUE: 0.53 | # QB: 0
Additional Sources for AROW Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle